Public procurement notice: Voluntary Ex Ante Transparency Notice
Published: 2018-09-21
Buyer: Sykehusinnkjøp HF
Country: NO
Contract type: Supplies
Procedure: Contract award without prior publication
CPV classification: 33600000: Pharmaceutical products
Estimated value: 8600000 AED
Award criteria: Lowest price

Technical requirements: Additional contracts with Mundipharma AS after the tender contest LIS 1901 special pharmaceutical preparations.
Sykehusinnkjøp HF, Divisjon legemidler (LIS) is collecting tenders for medicines that are used by the Health Trusts. LIS has previously announced and held an open tender contest for special pharmaceutical preparations (“LIS 1901 Special Pharmaceutical Preparations”). The contest was for the active ingredients that were in accordance with the tender documentation, annex 3 — Active Ingredients List.
The tender deadline expired on 5.2.2018 at 12:00, and no tenders were received for all the processing forms of the ATC codes N02AA03, N02AA05 and N02AA55.
The active ingredients and the various processing forms were covered by the procurement as they were listed in annex 3 — Active Ingredients List.
This part of the contest was regarded as unsuccessful, due to a lack of tenders in the open tender contest. LIS has since undertaken market surveys in order to request possible deliveries of the processing forms in question. Based on these surveys, it is only Mundipharma AS who has provided information that they are capable of delivering in 2019.
Based on this, LIS intends to enter into contracts between the health trusts and Mundipharm AS, as LIS is of the opinion that there is the legal basis to enter into a contract with Mundipharma AS for the missing processing forms, (see the attached excel file), as an additional contract to LIS 1901 Special Pharmaceutical Preparations, i.e. the extent and length of the contract will follow the mentioned procurement, (including access to extensions and notice), without a (new) competition being announced for these active ingredients/processing forms. See the procurement regulations, § 21-5, cf. § 21-2 first section, cf. § 13-4 letter a, cf. § 13-3 letter b.
LIS requests that those who have objections to this submit feedback before the waiting period expires on 8.10.2018. If no objections are received, a contract will be signed after the waiting period has expired.
Sykehusinnkjøp HF, Divisjon legemidler (LIS) is collecting tenders for medicines that are used by the Health Trusts. LIS has previously announced and held an open tender contest for special pharmaceutical preparations ('LIS 1901 Special Pharmaceutical Preparations'). The contest was for the active ingredients that were in accordance with the tender documentation, annex 3 — Active Ingredients List.
The tender deadline expired on 05.02.2018 at 12.00, and no tenders were received for all the processing forms of the ATC codes N02AA03, N02AA05 and N02AA55.
The active ingredients and the various processing forms were covered by the procurement as they were listed in annex 3 — Active Ingredients List.
This part of the contest was regarded as unsuccessful, due to a lack of tenders in the open tender contest. LIS has since undertaken market surveys in order to request possible deliveries of the processing forms in question. Based on these surveys, it is only Mundipharma AS who has provided information that they are capable of delivering in 2019.
Based on this, LIS intends to enter into contracts between the health trusts and Mundipharm AS as LIS is of the opinion that there is the legal basis to enter into a contract with Mundipharma AS for the missing processing forms, (see the attached excel file), as an additional contract to LIS 1901 Special Pharmaceutical Preparations, i.e. the extent and length of the contract will follow the mentioned procurement, (including access to extensions and notice), without a (new) competition being announced for these active ingredients/processing forms. See the procurement regulations, § 21-5, cf. § 21-2 first section, cf. § 13-4 letter a, cf. § 13-3 letter b.
LIS requests that those who have objections to this submit feedback before the waiting period expires on 8.10.2018. If no objections are received, a contract will be signed after the waiting period has expired.


Winner: Mundipharma AS
Award value: 8600000